Technology
Health
Medical

Hancock Jaffe

$1.03
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (5.11%) As of 12:24 PM EDT today
+$0.05 (5.11%) Today

Why Robinhood?

You can buy or sell Hancock Jaffe and other stocks, options, ETFs, and crypto commission-free!

About HJLI

Hancock Jaffe Laboratories, Inc. Common Stock, also called Hancock Jaffe, is a development stage medical device company, which develops biologic-based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Read More Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.

Employees
Headquarters
Irvine, California
Founded
1999
Market Cap
13.87M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
84.74K
High Today
$1.06
Low Today
$0.96
Open Price
$0.98
Volume
233.16K
52 Week High
$3.57
52 Week Low
$0.87

Collections

Technology
Health
Medical
2017 IPO
US
North America

HJLI Earnings

-$1.06
-$0.75
-$0.44
-$0.13
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.